Fluid and Electrolytes Comprehensive Nursing Comprehensive Guide

Clinical Definitions and Terminology

  • Anuria: A clinical state characterized by the production of less than 100mL100\,mL of urine within a 2424-hour period.
  • Ascites: The abnormal accumulation of fluid within the peritoneal (abdominal) cavity.
  • Diaphoresis: A state of excessive or profuse sweating.
  • Dysuria: Painful, labored, or difficult urination.
  • Glucosuria: The presence of glucose in the urine.
  • Hematuria: The presence of blood in the urine.
  • Ketonuria: The presence of ketones in the urine, typically observed in cases of diabetes mellitus or starvation.
  • Micturition: The physiological process of discharging urine from the bladder; urination.
  • Oliguria: Significantly decreased urine output, defined as less than 400mL400\,mL in a 2424-hour period.
  • Polyuria: Excessively high urine output, defined as greater than 2,5003,000mL2,500\text{--}3,000\,mL in a 2424-hour period.
  • Proteinuria: The presence of abnormal amounts of protein in the urine.
  • Pyuria: The presence of pus or white blood cells in the urine, often indicating infection.
  • Distention: The abnormal swelling or enlargement of a body cavity, such as the abdomen.
  • Edema: The accumulation of excess fluid in the interstitial spaces, resulting in visible swelling.
  • Diuretic: A classification of medication designed to increase urine output to facilitate the removal of excess fluid from the body.

Fluid Fundamentals and Body Composition

  • Body Water Composition: The human body is composed of approximately 45%75%45\%\text{--}75\% water. Fluid is distributed between two primary compartments:
    • Intracellular Fluid (ICF): Fluid found inside the cells.
    • Extracellular Fluid (ECF): Fluid found outside the cells, including intravascular (plasma) and interstitial fluid.
  • Fluid Distribution by Demographic:
    • Intracellular Fluid (ICF) holdings: Males (45%45\%), Females (35%35\%), Infants (48%48\%).
    • Intravascular Fluid holdings: Males (4%4\%).
  • Primary Functions of Body Water:
    1. Transportation of nonelectrolytes.
    2. Transportation of electrolytes.
    3. Removal and transportation of metabolic waste products.
  • Fluid Regulation Formula: To determine the daily fluid requirement based on weight:
    • Daily fluid requirement=Weight (kg)×30mL=mL/day\text{Daily fluid requirement} = \text{Weight (kg)} \times 30\,mL = mL/day
    • Example Calculation: For a patient weighing 75kg75\,kg: 75kg×30mL=2,250mL/day75\,kg \times 30\,mL = 2,250\,mL/day.
  • Normal 2424-Hour Intake and Output (I&O):
    • Intake: Typically ranges between 1,2002,500mL1,200\text{--}2,500\,mL. Clinically, intake should be slightly higher than output to account for insensible losses.
    • Output: Should roughly approximate intake, minus insensible loss.
  • Mechanisms of Fluid Movement:
    • Osmosis: The movement of water across a semi-permeable membrane following a concentration gradient. Normal plasma osmolarity ranges from 275300mOsm/L275\text{--}300\,mOsm/L.
    • Diffusion: The movement of solutes from an area of higher concentration to an area of lower concentration.

Physiological Regulation of Homeostasis

  • The Kidneys (Nephron): The nephron serves as the basic structural and functional unit of the kidney. When the body experiences dehydration, the kidneys initiate mechanisms to conserve water and concentrate urine.
  • Adrenal Glands: These glands secrete aldosterone, a mineralocorticoid, from the adrenal cortex. Aldosterone acts on the kidneys to retain sodium (Na+Na^+) and water while promoting the excretion of potassium (K+K^+).
  • Pituitary Gland (Antidiuretic Hormone): The pituitary releases Antidiuretic Hormone (ADH) to regulate water retention. ADH acts to keep fluid within the body by signaling the kidneys to reabsorb water.
  • Nervous System and Hypothalamus: The hypothalamus acts as the thirst control center. It is triggered when plasma osmolarity increases (indicating hemoconcentration/dehydration).
  • Parathyroid Glands: These glands regulate calcium (Ca2+Ca^{2+}) levels in the blood, which is vital for neuromuscular function and bone health.
  • Heart and Lungs:
    • Heart: Assists in regulating blood pressure and overall fluid volume.
    • Lungs: Contain the ACE enzyme (Angiotensin-Converting Enzyme), which converts Angiotensin I into Angiotensin II, a potent vasoconstrictor that helps maintain blood pressure.

Intravenous Fluid Therapy

  • Isotonic Solutions:
    • Osmolarity: Same as the body (275300mOsm/L275\text{--}300\,mOsm/L).
    • Effect on Cells: No change in cell size; fluid remains primarily in the extracellular fluid (ECF) compartment.
    • Movement: Minimal osmosis occurs.
    • Clinical Purpose: Extracellular volume replacement.
    • Examples: 0.9%NaCl0.9\% NaCl (Normal Saline), D5WD5W (5%5\% Dextrose in Water), Ringer's Lactate (RL).
    • Special Notes: Lactate in RL helps maintain acid-base balance. Contraindication: Avoid RL in patients with liver disease as the liver may not be able to metabolize the lactate.
  • Hypertonic Solutions:
    • Osmolarity: Higher than the body's plasma osmolarity.
    • Effect on Cells: Cells shrink as water is drawn out (plasmolysis).
    • Movement: Fluid is drawn from the cells into the intravascular space.
    • Clinical Purpose: To decrease cerebral edema or rapidly expand intravascular volume.
    • Examples: D10%WD10\%W, D50.45%NSD5\,0.45\% NS, D50.9%NSD5\,0.9\% NS.
    • Contraindications: Avoid in patients with impaired heart or kidney function due to the risk of fluid overload.
  • Hypotonic Solutions:
    • Osmolarity: Lower than the body's plasma osmolarity.
    • Effect on Cells: Cells swell as water enters the cell (cytolysis).
    • Movement: Fluid moves from the intravascular space into the cells.
    • Clinical Purpose: To treat cellular dehydration.
    • Examples: 0.45%NaCl0.45\% NaCl (12\frac{1}{2} Normal Saline).
    • Contraindications: Do not administer to patients with increased intracranial pressure (ICP\uparrow ICP), burns, or third-spacing.

Fluid Imbalances: Hypovolemia and Hypervolemia

  • Hypovolemia (Fluid Volume Deficit):
    • Definition: Decreased water in the ECF, creating a risk for dehydration in both intracellular and extracellular compartments.
    • Nursing Diagnosis: Deficient Fluid Volume.
    • Causes: Decreased intake, excessive fluid loss, third spacing, or decreased albumin levels.
    • Clinical Manifestations:
      • Weight: Weight loss.
      • Vital Signs: Elevated temperature; rapid, weak pulse; rapid, shallow respirations; low blood pressure (orthostatic hypotension).
      • Integument: Warm, dry, flushed skin; dry and sticky mucous membranes; poor skin turgor.
      • Appearance: Sunken eyes; flat neck veins.
      • Urine: Dark, concentrated urine with high specific gravity and oliguria.
      • Labs: Elevated Hematocrit (H&H), increased Blood Urea Nitrogen (BUNBUN), and increased specific gravity.
    • Treatment: Increase fluid intake to greater than 2,500mL2,500\,mL, monitor I&O, take daily weights, and administer isotonic IV fluids.
    • Severe Risk: Hypovolemic shock (occurs when there is a greater than 15%15\% loss of intravascular volume).
  • Hypervolemia (Fluid Volume Overload):
    • Definition: Excessive fluid accumulation in the extracellular compartment.
    • Nursing Diagnosis: Excess Fluid Volume.
    • Causes: Renal failure (decreased output), heart failure, or excessive sodium intake.
    • Clinical Manifestations:
      • Weight: Weight gain.
      • Vital Signs: Normal temperature; full, bounding pulse; moist, labored respirations (crackles/rale sounds).
      • Integument: Cool, pale skin.
      • Appearance: Visible edema; bulging/distended neck veins (JVD).
      • Urine: Light, clear, dilute urine with low specific gravity and polyuria.
      • Labs: Low Hematocrit (H&H) due to hemodilution.
    • Treatment: Administer diuretics, restrict fluid intake, and monitor I&O and daily weights.

Third-Spacing and Compartmental Shifts

  • Pathophysiology: Third spacing occurs when intravascular fluid shifts from the vascular system into a non-vascular compartment (transcellular space) where it becomes trapped and unavailable for use by the body.
  • Primary Cause: The loss of plasma proteins, specifically albumin. This reduction in colloid osmotic pressure allows fluid to leak out of the vessels. Common causes include burns, cirrhosis, and extensive tissue trauma.
  • Clinical Presentation: The symptoms mimic hypovolemia despite the presence of fluid in the body: low blood pressure, potential for shock, and circulatory failure.
  • Intervention: Administration of IV albumin to restore colloid osmotic pressure and pull the trapped fluid back into the intravascular space.
  • Contraindication: Hypotonic IV solutions (such as 0.45%NaCl0.45\% NaCl) are strictly avoided as they would further exacerbate the shift of fluid out of the vasculature.

Clinical Assessment of Fluids and Electrolytes

  • General Survey (Weight Analysis):
    • Weights must be recorded using the same scale, at the same time of day, with the same type of clothing.
    • Conversion: 1lb475mL1\,lb \approx 475\,mL of fluid.
  • Health History - Fluids: Inquiry should include quantity of fluid intake, dietary habits, and any changes in urination patterns.
  • Health History - Electrolytes: Inquiry should include presence of muscle weakness, cardiac arrhythmias, or history of seizures.
  • Physical Examination:
    • Inspection/Palpation: Assess Level of Consciousness (LOCLOC), skin texture, color, and turgor.
    • Auscultation: Lung sounds (moist crackles indicate fluid overload) and heart sounds.
  • Critical Laboratory Normals:
    • Hematocrit (HCT): Males (42%52%42\%\text{--}52\%), Females (36%48%36\%\text{--}48\%).
    • Hemoglobin (Hgb): Males (1417g/dL14\text{--}17\,g/dL), Females (1216g/dL12\text{--}16\,g/dL).

Major Electrolyte Profiles

Sodium (Na+Na^+)
  • Normal Range: 135145mEq/L135\text{--}145\,mEq/L.
  • Distribution: Found primarily in the ECF (90%90\% of total body sodium).
  • Functions: Maintains fluid volume, supports nervous system and muscle cell activity.
  • Dietary Sources: Table salt, processed meats.
  • Hyponatremia (<135mEq/L< 135\,mEq/L):
    • Causes: Kidney/adrenal disease, GI loss, diaphoresis, diuretics, or excessive intake of plain water without electrolytes.
    • Manifestations: Personality changes, hypotension, abdominal cramping, nausea and vomiting (N&V), muscle weakness. Severe: Seizures, coma.
    • Treatment: Oral or IV sodium replacement; implement seizure precautions.
  • Hypernatremia (>145mEq/L> 145\,mEq/L):
    • Causes: Increased sodium intake, severe burns.
    • Manifestations: Intense thirst, dry mucous membranes, neurologic changes.
    • Treatment: Administration of plain water or hypotonic fluids.
Potassium (K+K^+)
  • Normal Range: 3.55.0mEq/L3.5\text{--}5.0\,mEq/L.
  • Distribution: Most abundant in the ICF and GI secretions.
  • Functions: Maintains cellular activity, transmits nerve/muscle impulses.
  • Dietary Sources: Fruits and vegetables, specifically bananas.
  • Hypokalemia (<3.5mEq/L< 3.5\,mEq/L):
    • Causes: Potassium-wasting diuretics, GI loss (diarrhea, vomiting, or NG tube suction).
    • Manifestations: Weakness, fatigue, paresthesia, decreased muscle tone. Severe: Paralysis and cardiac arrest/death.
    • Treatment: IV potassium replacement. Safety Protocol: Must not exceed 10mEq/hr10\,mEq/hr. NEVER give potassium via IV push.
  • Hyperkalemia (>5.0mEq/L> 5.0\,mEq/L):
    • Causes: Renal failure, fluid volume deficit.
    • Manifestations: Abdominal cramps, paresthesia. Severe: ECG dysrhythmias and death.
    • Treatment: Kayexalate (removes K+K^+ via bowel), or dialysis.
Calcium (Ca2+Ca^{2+})
  • Normal Range: 8.510.5mEq/L8.5\text{--}10.5\,mEq/L.
  • Distribution: Primarily found in bones and teeth.
  • Functions: Transmission of nerve impulses, blood clotting, bone structure maintenance.
  • Dietary Sources: Milk, beans.
  • Hypocalcemia (<8.5mEq/L< 8.5\,mEq/L):
    • Causes: Fast blood transfusions (citrate binds calcium), hypoparathyroidism, Vitamin D deficiency.
    • Manifestations: Paresthesia, hyperactive reflexes, tetany, seizures. Positive Trousseau Sign (carpal spasm when BP cuff is inflated) and Chvostek Sign (facial twitching when cheek is tapped).
    • Treatment: IV or oral calcium.
  • Hypercalcemia (>10.5mEq/L> 10.5\,mEq/L):
    • Causes: Hyperparathyroidism, prolonged immobilization, osteoporosis (leaching calcium from bones).
    • Manifestations: Low back pain (kidney stones), bone pain, anorexia.
    • Treatment: IV fluids, encouraging mobility/walking.
Magnesium (Mg2+Mg^{2+})
  • Normal Range: 1.82.6mEq/L1.8\text{--}2.6\,mEq/L.
  • Distribution: Found in the ICF and bones.
  • Functions: Enzyme activity, cardiac and skeletal muscle excitability.
  • Dietary Sources: Green leafy vegetables, nuts, whole grains, dark chocolate.
  • Hypomagnesemia (<1.8mEq/L< 1.8\,mEq/L):
    • Causes: Alcoholism, diarrhea, vomiting, NG tube suction, small intestine issues.
    • Manifestations: Muscle tremors, hyperactive Deep Tendon Reflexes (DTRsDTRs), confusion, disorientation, positive Chvostek and Trousseau signs.
    • Treatment: IV magnesium sulfate or oral magnesium.
  • Hypermagnesemia (>2.6mEq/L> 2.6\,mEq/L):
    • Causes: Renal failure, high intake of antacids, hyperthyroidism.
    • Manifestations: Hypoactive DTRsDTRs, decreased respiratory depth, hypotension, flushing.
    • Treatment: IV calcium gluconate (antagonizes magnesium), dialysis.

Ancillary Anions and Acid-Base Buffers

  • Chloride (ClCl^-): Normal range is 98108mEq/L98\text{--}108\,mEq/L. It is the chief extracellular anion. Sodium typically follows chloride. It is essential for the production of hydrochloric acid (HClHCl) in the stomach.
  • Phosphate: Normal range is 2.54.5mEq/L2.5\text{--}4.5\,mEq/L. An intracellular anion involved in acid-base balance, nerve/muscle activity, and bone/teeth health.
  • Bicarbonate (HCO3HCO_3^-): Arterial range is 2226mEq/L22\text{--}26\,mEq/L. A major chemical base buffer found in both ICF and ECF. It is formed within the body and is critical for maintaining blood pHpH.

Questions & Discussion

Q: When a nurse administers 0.9%NaCl0.9\% NaCl solution, what will happen to the patient's cells?A: They remain in the intravascular space (no change). Since 0.9%NaCl0.9\% NaCl is isotonic, it has the same osmolarity as body fluids, resulting in no fluid shift into or out of the cells.

Q: Which of the following are indicators of dehydration?A: Hypotension, increased temperature, and increased pulse. Dehydration causes low blood pressure (volume loss) and a compensatory increase in pulse and temperature.

Q: Which of the following patients is at LEAST risk for dehydration?A: A 6060-year-old taking potassium supplements. Unlike being NPO or having a draining wound/diarrhea, potassium supplements do not directly cause fluid loss.

Q: How does the body respond to a hypovolemic patient?A: The Renin-Angiotensin-Aldosterone System (RAASRAAS) is activated. Kidneys release renin, which leads to the production of Angiotensin II (causing vasoconstriction) and subsequently Aldosterone (causing Na+Na^+ and water retention).

Q: For a patient with hypovolemia, which interventions apply?A: Monitor I&O every 44 hours, perform daily weights at 6AM6\,AM, and instruct the patient to rise slowly from a sitting/lying position (to manage orthostatic hypotension).

Q: Which patient is MOST at risk for fluid volume OVERLOAD?A: A 3535-year-old with kidney failure. Kidney failure severely limits urine output, leading to systemic fluid retention.

Q: If an elderly patient is receiving 0.45%NS0.45\% NS at 150mL/hr150\,mL/hr, which symptom alerts the nurse to a complication?A: Confusion and seizures. 0.45%NaCl0.45\% NaCl is hypotonic; it causes cells to swell. If brain cells swell (cerebral edema), neurologic symptoms occur.

Q: A sodium level of 130mEq/L130\,mEq/L reflects hyponatremia. Which patient is at highest risk?A: A patient taking diuretics. Thiazide and loop diuretics are common causes of sodium loss.

Q: What is the first action for a serum K+K^+ of 2.0mEq/L2.0\,mEq/L?A: Tell the healthcare provider immediately. A level of 2.02.0 is critically low and can lead to fatal cardiac arrest.

Q: Why does a patient with hypoparathyroidism experience numbness/tingling?A: This is due to hypocalcemia. A lack of parathyroid hormone leads to low serum calcium, causing neuromuscular irritability.